AU2002241720A1 - Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer - Google Patents
Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancerInfo
- Publication number
- AU2002241720A1 AU2002241720A1 AU2002241720A AU4172002A AU2002241720A1 AU 2002241720 A1 AU2002241720 A1 AU 2002241720A1 AU 2002241720 A AU2002241720 A AU 2002241720A AU 4172002 A AU4172002 A AU 4172002A AU 2002241720 A1 AU2002241720 A1 AU 2002241720A1
- Authority
- AU
- Australia
- Prior art keywords
- kits
- assessment
- therapy
- prevention
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010033128 Ovarian cancer Diseases 0.000 title 1
- 206010061535 Ovarian neoplasm Diseases 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57449—Specifically defined cancers of ovaries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24683900P | 2000-11-08 | 2000-11-08 | |
| US60/246,839 | 2000-11-08 | ||
| PCT/US2001/050489 WO2002046765A2 (fr) | 2000-11-08 | 2001-11-08 | Compositions, trousses, et methodes d'identification, d'evaluation, de prevention et de traitement de cancers de l'ovaire |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002241720A1 true AU2002241720A1 (en) | 2002-06-18 |
Family
ID=22932445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002241720A Abandoned AU2002241720A1 (en) | 2000-11-08 | 2001-11-08 | Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20020182619A1 (fr) |
| AU (1) | AU2002241720A1 (fr) |
| WO (1) | WO2002046765A2 (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030087250A1 (en) * | 2001-03-14 | 2003-05-08 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| US7270960B2 (en) * | 2001-08-29 | 2007-09-18 | Pacific Northwest Research Institute | Diagnosis of ovarian carcinomas |
| CA2516591A1 (fr) * | 2003-02-26 | 2004-09-10 | Mount Sinai Hospital | Dosage a marqueurs multiples utilise pour depister un cancer des ovaires |
| ES2394799T3 (es) * | 2003-12-31 | 2013-02-05 | The Penn State Research Foundation | Métodos para predecir y superar la resistencia a quimioterapia en cáncer de ovario |
| CN101473041B (zh) * | 2006-01-04 | 2017-11-14 | 富士瑞必欧美国公司 | He4与其它生化标记物在评估子宫内膜癌和子宫癌中的应用 |
| MX2008009592A (es) * | 2006-01-27 | 2008-09-08 | Tripath Imaging Inc | Metodos y composiciones para identificar pacientes con una probabilidad incrementada de tener cancer de ovario. |
| AU2008226587A1 (en) * | 2007-03-09 | 2008-09-18 | Tripath Imaging, Inc. | HE4 monoclonal antibodies and methods for their use |
| JP5144742B2 (ja) * | 2007-03-29 | 2013-02-13 | フジレビオ ダイアグノスティックス インコーポレイテッド | 乳がんの評価のためのhe4の使用 |
| WO2009076598A1 (fr) | 2007-12-12 | 2009-06-18 | Children's Hospital & Research Center At Oakland | Utilisation de composés de sphingosine insaturée en tant qu'agents chimiothérapeutiques pour le traitement du cancer |
| RU2600891C2 (ru) * | 2010-08-26 | 2016-10-27 | Юниверсити Оф Вашингтон Тру Итс Сентер Фор Коммерсиализейшен | Способы выявления антител против не4 и способы диагностики и/или прогнозирования состояний, ассоциированных с экспрессирующими не4 клетками |
| EP3249399A1 (fr) * | 2011-09-22 | 2017-11-29 | Memorial Sloan-Kettering Cancer Center | Détection du cancer ovarien |
| EP2809801B1 (fr) * | 2012-01-31 | 2018-07-25 | Speiser, Paul | Diagnostic non invasif du cancer |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5242813A (en) * | 1990-10-12 | 1993-09-07 | The United States Of America As Represented By The Department Of Health And Human Services | Mouse monoclonal antibodies specific for normal primate tissue, malignant human cultural cell lines human tumors |
| US5871941A (en) * | 1995-07-28 | 1999-02-16 | Univ British Columbia | Method of testing expression of CA125 antigen in cultured ovarian surface epithelial cells to identify and monitor individuals having a predisposition to develop ovarian cancer |
| WO1998024935A1 (fr) * | 1996-12-06 | 1998-06-11 | Urocor, Inc. | DIAGNOSTIC D'ETAT PATHOLOGIQUE A L'AIDE DE PROFILS d'ARN MESSAGER |
| AU6468998A (en) * | 1997-03-19 | 1998-10-12 | Board Of Trustees Of The University Of Arkansas, The | Compositions and method for the early diagnosis of ovarian cancer |
| US5965377A (en) * | 1997-03-24 | 1999-10-12 | Baystate Medical Center | Method for determining the presence of mutated BRCA protein |
| AU7701100A (en) * | 1999-09-03 | 2001-04-10 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer |
-
2001
- 2001-11-08 WO PCT/US2001/050489 patent/WO2002046765A2/fr not_active Ceased
- 2001-11-08 AU AU2002241720A patent/AU2002241720A1/en not_active Abandoned
- 2001-11-08 US US10/035,415 patent/US20020182619A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002046765A2 (fr) | 2002-06-13 |
| WO2002046765A3 (fr) | 2003-08-21 |
| US20020182619A1 (en) | 2002-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002322280A1 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| AU4592601A (en) | Novel genes, compositions, kits, and method for identification, assessment, prevention, and therapy of ovarian cancer | |
| AU2002324451A1 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer | |
| AU2002337657A1 (en) | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer | |
| AU2001229340A1 (en) | Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| AU2001241541A1 (en) | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of human prostate cancer | |
| AU2074201A (en) | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer | |
| AU2001236519A1 (en) | Identification, assessment, prevention, and therapy of prostate cancer | |
| AU2002365166A1 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis | |
| AU2001265296A1 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
| AU2003293194A1 (en) | Compositions and methods for treating prostate cancer | |
| AU2003230750A1 (en) | Compositions and methods for treating cancer | |
| AU7701100A (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer | |
| AU2003226676A1 (en) | Methods and compositions for the identification, assessment, and therapy of small cell lung cancer | |
| AU2003225535A1 (en) | Methods and compositions for treating cancer | |
| AU2001251613A1 (en) | Novel genes, compositions and methods for the identification, assessment, prevention, and therapy of human cancers | |
| AU2001245295A1 (en) | Methods and compositions for the identification, assessment, prevention and therapy of human cancers | |
| AU2002364708A1 (en) | Novel compositions and methods for cancer | |
| AU2002241720A1 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer | |
| AU2596901A (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| AU2074101A (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer | |
| AU2002239431A1 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
| AU2001238493A1 (en) | Methods and compositions for the identification, assessment, prevention and therapy of human cancers | |
| AU2001249317A1 (en) | Compositions and methods for the therapy and diagnosis of ovarian and endometrial cancer | |
| AU2002337943A1 (en) | Novel compositions and methods for cancer |